Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Barry Uretsky to Male

This is a "connection" page, showing publications Barry Uretsky has written about Male.

 
Connection Strength
  
 
 
2.072
  
  1. Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
    View in: PubMed
    Score: 0.050
  2. Birnbaum Y, Levine GN, French J, Kaski JC, Atar D, Alam M, Hasdai D, Jneid H, Uretsky BF. Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines? Cardiovasc Drugs Ther. 2020 12; 34(6):865-870.
    View in: PubMed
    Score: 0.045
  3. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention. J Am Heart Assoc. 2020 02 04; 9(3):e015073.
    View in: PubMed
    Score: 0.043
  4. Hakeem A, Ghosh B, Shah K, Agarwal S, Kasula S, Hacioglu Y, Bhatti S, Ahmed Z, Uretsky B. Incremental Prognostic Value of Post-Intervention Pd/Pa in Patients Undergoing Ischemia-Driven Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 10 28; 12(20):2002-2014.
    View in: PubMed
    Score: 0.042
  5. Rafeedheen R, Agarwal SK, Meek JC, Uretsky BF. Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it. Catheter Cardiovasc Interv. 2020 05 01; 95(6):1136-1140.
    View in: PubMed
    Score: 0.042
  6. Siraj A, Pattanshetty DJ, Agarwal SK, Uretsky BF. Retrograde recanalization of a nonchronic total occlusion lesion. Catheter Cardiovasc Interv. 2018 12 01; 92(7):1293-1296.
    View in: PubMed
    Score: 0.039
  7. Vallurupalli S, Garg A, Carlino M, Hakeem A, Uretsky BF. Full stent expansion of chronic total occlusion lesions requires prolonged inflation. Cardiovasc Revasc Med. 2018 06; 19(4):403-406.
    View in: PubMed
    Score: 0.037
  8. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):225-232.
    View in: PubMed
    Score: 0.035
  9. Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NVK, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF. A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation deployment method. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):233-240.
    View in: PubMed
    Score: 0.035
  10. Hakeem A, Edupuganti MM, Almomani A, Pothineni NV, Payne J, Abualsuod AM, Bhatti S, Ahmed Z, Uretsky BF. Long-Term Prognosis of Deferred Acute?Coronary Syndrome Lesions Based on Nonischemic Fractional?Flow?Reserve. J Am Coll Cardiol. 2016 09 13; 68(11):1181-1191.
    View in: PubMed
    Score: 0.034
  11. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions. J Invasive Cardiol. 2016 Mar; 28(3):94-7.
    View in: PubMed
    Score: 0.033
  12. Hakeem A, Garg A, Bhatti S, Ahmed Z, Uretsky BF. Fractional flow reserve in acute coronary syndrome: a word of caution. EuroIntervention. 2015 Dec; 11(8):e1-2.
    View in: PubMed
    Score: 0.032
  13. Vallurupalli S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, Hakeem A, Uretsky BF. Optimization of stent implantation using a high pressure inflation protocol. Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):65-72.
    View in: PubMed
    Score: 0.031
  14. Hakeem A, Uretsky BF. "Just do it!" redux. Catheter Cardiovasc Interv. 2015 May; 85(6):977-8.
    View in: PubMed
    Score: 0.031
  15. Assad-Kottner C, Hakeem A, Uretsky BF. Modified dual guide catheter ("ping-pong") technique to treat left internal mammary artery graft perforation. Catheter Cardiovasc Interv. 2015 Jul; 86(1):E28-31.
    View in: PubMed
    Score: 0.031
  16. Uretsky BF, Carlino M. How to improve your "STAR quality". Catheter Cardiovasc Interv. 2015 Feb 15; 85(3):391-2.
    View in: PubMed
    Score: 0.031
  17. Hakeem A, Uretsky B. Regadenoson for FFR: time to say good-bye to adenosine? Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):375-6.
    View in: PubMed
    Score: 0.029
  18. Garg N, Hakeem A, Gobal F, Uretsky BF. Outcomes of percutaneous coronary intervention of chronic total saphenous vein graft occlusions in the contemporary era. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1025-32.
    View in: PubMed
    Score: 0.028
  19. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Rebuttal: response to letter by Fan and colleagues regarding "impact on fractional flow reserve of donor artery by chronic total obstruction revascularization". Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1197.
    View in: PubMed
    Score: 0.027
  20. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Reversal of ischemia of donor artery myocardium after recanalization of a chronic total occlusion. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E453-8.
    View in: PubMed
    Score: 0.027
  21. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014 Jan 01; 83(1):9-16.
    View in: PubMed
    Score: 0.027
  22. Uretsky BF. Pathophysiology and prognosis: the curious case of the periprocedural myocardial infarction. Catheter Cardiovasc Interv. 2013 May; 81(6):968-9.
    View in: PubMed
    Score: 0.027
  23. Cook JR, Mhatre A, Wang FW, Uretsky BF. Prolonged high-pressure is required for optimal stent deployment as assessed by optical coherence tomography. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):521-7.
    View in: PubMed
    Score: 0.027
  24. Deshmukh AJ, Pant S, Cook J, Sachdeva R, Rutlen D, Uretsky BF. Prasugrel-induced rash. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1123-5.
    View in: PubMed
    Score: 0.026
  25. Flynn SE, Sachdeva R, Uretsky BF. Symptomatic right ventricular ischemia secondary to a critical stenosis in a nondominant right coronary artery. Catheter Cardiovasc Interv. 2013 Jan 01; 81(1):68-72.
    View in: PubMed
    Score: 0.025
  26. Uretsky BF. Does mini-STAR equal mega-success? Catheter Cardiovasc Interv. 2012 Jan 01; 79(1):41-2.
    View in: PubMed
    Score: 0.025
  27. Uretsky BF. The value of recanalizing a chronic total occlusion. Catheter Cardiovasc Interv. 2011 Sep 01; 78(3):354-5.
    View in: PubMed
    Score: 0.024
  28. Gobal F, Sachdeva R, Uretsky BF. Computed tomography and angiography of left ventricular diverticulum. J Am Coll Cardiol. 2011 Aug 23; 58(9):e17.
    View in: PubMed
    Score: 0.024
  29. Wang FW, Esterbrooks D, Kuo YF, Mooss A, Mohiuddin SM, Uretsky BF. Outcomes after carotid artery stenting and endarterectomy in the Medicare population. Stroke. 2011 Jul; 42(7):2019-25.
    View in: PubMed
    Score: 0.024
  30. Willis N, Sachdeva R, Uretsky BF. Bare-metal stent thrombosis after noncardiac surgery greater than 10 years after stent implantation. Catheter Cardiovasc Interv. 2011 Aug 01; 78(2):234-6.
    View in: PubMed
    Score: 0.023
  31. Sachdeva R, Uretsky BF. The effect of CTO recanalization on FFR of the donor artery. Catheter Cardiovasc Interv. 2011 Feb 15; 77(3):367-9.
    View in: PubMed
    Score: 0.023
  32. Sudhakar S, Sewani A, Agrawal M, Uretsky BF. Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (MAIVF): A comprehensive review. J Am Soc Echocardiogr. 2010 Oct; 23(10):1009-18; quiz 1112.
    View in: PubMed
    Score: 0.023
  33. Uretsky BF. IIb or not IIb? Toward a rational application of left main stenting. J Am Coll Cardiol. 2010 Jun 08; 55(23):2553-5.
    View in: PubMed
    Score: 0.022
  34. Sachdeva R, Hughes B, Uretsky BF. Retrograde approach to a totally occluded right coronary artery via a septal perforator artery: the tale of a long and winding wire. J Invasive Cardiol. 2010 Apr; 22(4):E65-6.
    View in: PubMed
    Score: 0.022
  35. Sachdeva R, Uretsky BF. Retrograde recanalization of a chronic total occlusion of a saphenous vein graft. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):575-8.
    View in: PubMed
    Score: 0.021
  36. Uretsky BF. Optimizing bifurcation stenting: the SPRINT technique. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):344-5.
    View in: PubMed
    Score: 0.020
  37. Uretsky BF, Birnbaum Y, Osman A, Gupta R, Paniagua O, Chamoun A, Pohwani A, Lui C, Lev E, McGehee T, Kumar D, Akhtar A, Anzuini A, Schwarz ER, Wang FW. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv. 2008 Oct 01; 72(4):488-97.
    View in: PubMed
    Score: 0.020
  38. Bansal D, Uretsky BF. Treatment of chronic total occlusion by retrograde passage of stents through an epicardial collateral vessel. Catheter Cardiovasc Interv. 2008 Sep 01; 72(3):365-369.
    View in: PubMed
    Score: 0.020
  39. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Card Fail. 2008 Oct; 14(8):670-5.
    View in: PubMed
    Score: 0.019
  40. Schwarz ER, Gupta R, Haager PK, vom Dahl J, Klues HG, Minartz J, Uretsky BF. Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up. Cardiology. 2009; 112(1):13-21.
    View in: PubMed
    Score: 0.019
  41. Birnbaum Y, Lin Y, Ye Y, Merla R, Perez-Polo JR, Uretsky BF. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat. J Cardiovasc Pharmacol Ther. 2008 Mar; 13(1):72-9.
    View in: PubMed
    Score: 0.019
  42. Birnbaum Y, Lin Y, Ye Y, Martinez JD, Huang MH, Lui CY, Perez-Polo JR, Uretsky BF. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. Am J Physiol Heart Circ Physiol. 2007 Jun; 292(6):H2891-7.
    View in: PubMed
    Score: 0.018
  43. Salinas G, Kumar D, Lick S, Vijayakumar V, Rahman M, Uretsky BF. Infective coronary aneurysms: a complication of percutaneous coronary intervention. Tex Heart Inst J. 2007; 34(1):91-4.
    View in: PubMed
    Score: 0.017
  44. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Huang MH, Perez-Polo JR, Uretsky BF. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat. 2007 Feb; 83(1-2):89-98.
    View in: PubMed
    Score: 0.017
  45. Ahmad M, Jin Z, Xie T, Agoston I, Tiller F, Uretsky B. Live 3-d echocardiography in monitoring transcatheter closure of patent foramen ovale. Echocardiography. 2006 Jul; 23(6):525-7.
    View in: PubMed
    Score: 0.017
  46. Gupta R, Uretsky BF. Gadodiamide-based coronary angiography in a patient with severe renal insufficiency. J Interv Cardiol. 2005 Oct; 18(5):379-83.
    View in: PubMed
    Score: 0.016
  47. Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Hu ZY, Schwarz ER, Uretsky BF. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res. 2005 Feb 01; 65(2):345-55.
    View in: PubMed
    Score: 0.015
  48. Helmy TA, Nicholson WJ, Lick S, Uretsky BF. Contained myocardial rupture: a variant linking complete and incomplete rupture. Heart. 2005 Feb; 91(2):e13.
    View in: PubMed
    Score: 0.015
  49. Osman A, Otero J, Brizolara A, Waxman S, Stouffer G, Fitzgerald P, Uretsky BF. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. Am Heart J. 2004 May; 147(5):e23.
    View in: PubMed
    Score: 0.014
  50. Wang FW, Osman A, Otero J, Stouffer GA, Waxman S, Afzal A, Anzuini A, Uretsky BF. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation. 2003 Jun 17; 107(23):2914-9.
    View in: PubMed
    Score: 0.014
  51. Hwang D, Koo BK, Zhang J, Park J, Yang S, Kim M, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Pijls NHJ, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B. Prognostic Implications of Fractional Flow Reserve After Coronary Stenting: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 09 01; 5(9):e2232842.
    View in: PubMed
    Score: 0.013
  52. Salah HM, Almaddah N, Xu J, Al-Hawwas M, Agarwal SK, Uretsky BF, Dhar G, Al'Aref SJ. Gender Differences and Outcomes of Hypoattenuated Leaflet Thickening (HALT) Following Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized and Cohort Studies. Curr Probl Cardiol. 2023 Jul; 48(7):101155.
    View in: PubMed
    Score: 0.012
  53. Xenogiannis I, Rangan BV, Uyeda L, Banerjee S, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Mavromatis K, Ramanathan K, Bavry AA, McFalls EO, Garcia S, Thai H, Uretsky BF, Latif F, Armstrong E, Ortiz J, Jneid H, Liu J, Aggrawal K, Conner TA, Wagner T, Karacsonyi J, Ventura B, Alsleben A, Lu Y, Shih MC, Brilakis ES. In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial). Am J Cardiol. 2022 01 01; 162:24-30.
    View in: PubMed
    Score: 0.012
  54. Uretsky BF, Rosanio S, Lerakis S, Wang FW, Smiley M, Stouffer GA, Tocchi M, Estella P. A prospective evaluation of angiography-guided coronary stent implantation with high versus very high balloon inflation pressure. Am Heart J. 2000 Nov; 140(5):804-12.
    View in: PubMed
    Score: 0.011
  55. Walsh SJ, Dudek D, Bryniarski L, Nicholson W, Karmpaliotis D, Uretsky B, McEntegart M, Assali A, Knaapen P, Kornowski R, Spratt JC, Goodwin M, Hanratty CG. Safety and efficacy of the NovaCross microcatheter in facilitating crossing of chronic total occlusion coronary lesions: a multicenter, single-arm clinical trial. Coron Artery Dis. 2020 11; 31(7):573-577.
    View in: PubMed
    Score: 0.011
  56. Nairooz R, Parzynski CS, Curtis JP, Mohsen A, McNulty E, Uretsky BF, Hakeem A. Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry). Am J Cardiol. 2020 09 01; 130:37-45.
    View in: PubMed
    Score: 0.011
  57. deFilippi CR, Tocchi M, Parmar RJ, Rosanio S, Abreo G, Potter MA, Runge MS, Uretsky BF. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol. 2000 Jun; 35(7):1827-34.
    View in: PubMed
    Score: 0.011
  58. Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Krestyaninov O, Khelimskii D, Jaffer FA, Khatri JJ, Kandzari DE, Wyman RM, Doing AH, Dattilo P, Toma C, Yeh RW, Tamez H, Choi JW, Jaber W, Samady H, Sheikh AM, Potluri S, Patel M, Mahmud E, Elbaruni B, Love MP, Koutouzis M, Tsiafoutis I, Jefferson BK, Patel T, Uretsky B, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Hall AB, Megaly MS, Vemmou E, Nikolakopoulos I, Rangan BV, Morley PW, Bou Dargham B, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES, Alaswad K. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via?Saphenous Vein Graft. JACC Cardiovasc Interv. 2020 02 24; 13(4):517-526.
    View in: PubMed
    Score: 0.011
  59. Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong HT, Kinlay S, Papademetriou V, Velagaleti RS, Rangan BV, Mavromatis K, Shih MC, Banerjee S, Brilakis ES. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial. Circ Cardiovasc Interv. 2020 02; 13(2):e008494.
    View in: PubMed
    Score: 0.011
  60. Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Alaswad K, Krestyaninov O, Khelimskii D, Choi JW, Jaffer FA, Patel M, Mahmud E, Khatri JJ, Kandzari DE, Doing AH, Dattilo P, Toma C, Koutouzis M, Tsiafoutis I, Uretsky B, Yeh RW, Tamez H, Wyman RM, Jefferson BK, Patel T, Jaber W, Samady H, Sheikh AM, Malik BA, Holper E, Potluri S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Hall AB, Vemmou E, Nikolakopoulos I, Dargham BB, Rangan BV, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES. The Impact of Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention (Insights From PROGRESS-CTO Registry). Angiology. 2020 03; 71(3):274-280.
    View in: PubMed
    Score: 0.011
  61. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Ryd?n L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999 Dec 07; 100(23):2312-8.
    View in: PubMed
    Score: 0.011
  62. Xenogiannis I, Choi JW, Alaswad K, Khatri JJ, Doing AH, Dattilo P, Jaffer FA, Uretsky B, Krestyaninov O, Khelimskii D, Patel M, Mahmud E, Potluri S, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Jefferson BK, Patel T, Megaly MS, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
    View in: PubMed
    Score: 0.011
  63. Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Tajti P, Hall AB, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention. Int J Cardiol. 2020 01 15; 299:75-80.
    View in: PubMed
    Score: 0.010
  64. Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv. 2019 03; 12(3):e007338.
    View in: PubMed
    Score: 0.010
  65. Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry. JACC Cardiovasc Interv. 2019 02 25; 12(4):346-358.
    View in: PubMed
    Score: 0.010
  66. Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry). Am J Cardiol. 2019 05 01; 123(9):1422-1428.
    View in: PubMed
    Score: 0.010
  67. Sandoval Y, Tajti P, Karatasakis A, Burke MN, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Krestyaninov O, Khelimskii D, Choi JW, Doing AH, Toma C, Wyman RM, Uretsky B, Garcia S, Koutouzis M, Tsiafoutis I, Holper E, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Kandzari DE, Karacsonyi J, Rangan BV, Thompson C, Banerjee S, Brilakis ES. Frequency and Outcomes of Ad Hoc Versus Planned Chronic Total Occlusion Percutaneous Coronary Intervention: Multicenter Experience. J Invasive Cardiol. 2019 May; 31(5):133-139.
    View in: PubMed
    Score: 0.010
  68. Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Comparison Between Traditional and Guide-Catheter Extension Reverse Controlled Antegrade Dissection and Retrograde Tracking: Insights From the PROGRESS-CTO Registry. J Invasive Cardiol. 2019 01; 31(1):27-34.
    View in: PubMed
    Score: 0.010
  69. Tajti P, Karatasakis A, Danek BA, Alaswad K, Karmpaliotis D, Jaffer FA, Choi JW, Yeh RW, Patel M, Mahmud E, Burke MN, Krestyaninov O, Khelimskii D, Toma C, Doing AH, Uretsky B, Koutouzis M, Tsiafoutis I, Wyman RM, Garcia S, Holper E, Xenogiannis I, Rangan BV, Banerjee S, Ungi I, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. J Invasive Cardiol. 2018 11; 30(11):E113-E121.
    View in: PubMed
    Score: 0.010
  70. Tajti P, Burke MN, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Datilo P, Toma C, Smith AJC, Uretsky B, Holper E, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Jaber W, Samady H, Rangan BV, Xenogiannis I, Ungi I, Banerjee S, Brilakis ES. Prevalence and Outcomes of Percutaneous Coronary Interventions for Ostial Chronic Total Occlusions: Insights From a Multicenter Chronic Total Occlusion Registry. Can J Cardiol. 2018 10; 34(10):1264-1274.
    View in: PubMed
    Score: 0.010
  71. Almomani A, Pothineni NV, Edupuganti M, Payne J, Agarwal S, Uretsky B, Hakeem A. Outcomes of Fractional Flow Reserve-Based Deferral in Saphenous Vein Graft Narrowing. Am J Cardiol. 2018 09 01; 122(5):723-728.
    View in: PubMed
    Score: 0.010
  72. Saad M, Bavineni M, Uretsky BF, Vallurupalli S. Improved stent expansion with prolonged compared with short balloon inflation: A meta-analysis. Catheter Cardiovasc Interv. 2018 11 01; 92(5):873-880.
    View in: PubMed
    Score: 0.010
  73. Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Toma C, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure. Am J Cardiol. 2018 08 01; 122(3):381-387.
    View in: PubMed
    Score: 0.010
  74. Runge MS, Stouffer GA, Sheahan RG, Uretsky BF. Perspectives on coronary stenting. Am J Med Sci. 1998 May; 315(5):322-6.
    View in: PubMed
    Score: 0.010
  75. Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES. The Hybrid Approach to Chronic?Total?Occlusion Percutaneous?Coronary?Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018 07 23; 11(14):1325-1335.
    View in: PubMed
    Score: 0.010
  76. Pothineni NVK, Edupuganti MM, Almomani A, Payne J, Raina S, Fnu S, Abualsuod A, Wong J, Uretsky BF, Hakeem A. Comparison of the prognostic value of non-ischaemic fractional flow reserve using intracoronary versus intravenous adenosine. EuroIntervention. 2018 02 20; 13(14):1680-1687.
    View in: PubMed
    Score: 0.009
  77. Tajti P, Karmpaliotis D, Alaswad K, Toma C, Choi JW, Jaffer FA, Doing AH, Patel M, Mahmud E, Uretsky B, Karatasakis A, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry. Catheter Cardiovasc Interv. 2018 03 01; 91(4):657-666.
    View in: PubMed
    Score: 0.009
  78. Stouffer GA, Uretsky BF. Hemodynamic changes of aortic regurgitation. Am J Med Sci. 1997 Dec; 314(6):411-4.
    View in: PubMed
    Score: 0.009
  79. Tajti P, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Toma C, Uretsky B, Garcia S, Moses JW, Parikh M, Kirtane A, Ali ZA, Hatem R, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry. J Invasive Cardiol. 2018 03; 30(3):89-96.
    View in: PubMed
    Score: 0.009
  80. Lerakis S, Cutler D, Zhao D, Conti VR, Uretsky BF. Relation of unstable angina and myocardial infarction to progression of coronary narrowing in patients undergoing coronary artery bypass grafting (utilizing an internal mammary artery). Am J Cardiol. 1997 Jun 15; 79(12):1683-5.
    View in: PubMed
    Score: 0.009
  81. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Doing A, Toma C, Uretsky B, Choi J, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Martinez-Parachini JR, Karatasakis A, Danek BA, Alame AJ, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. J Invasive Cardiol. 2017 Aug; 29(8):264-270.
    View in: PubMed
    Score: 0.009
  82. Parmar RJ, Uretsky BF. Obliteration of a coronary artery aneurysm with percutaneous transluminal coronary angioplasty and stent placement. Cathet Cardiovasc Diagn. 1997 May; 41(1):51-2.
    View in: PubMed
    Score: 0.009
  83. Agarwal SK, Kasula S, Edupuganti MM, Raina S, Shailesh F, Almomani A, Payne JJ, Pothineni NV, Uretsky BF, Hakeem A. Clinical Decision-Making for the Hemodynamic "Gray Zone" (FFR 0.75-0.80) and Long-Term Outcomes. J Invasive Cardiol. 2017 Nov; 29(11):371-376.
    View in: PubMed
    Score: 0.009
  84. Karatasakis A, Iwnetu R, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Kandzari DE, Lembo NJ, Patel M, Mahmud E, Lombardi WL, Wyman RM, Grantham JA, Doing AH, Toma C, Choi JW, Uretsky BF, Moses JW, Kirtane AJ, Ali ZA, Parikh M, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2017 Apr; 29(4):116-122.
    View in: PubMed
    Score: 0.009
  85. Agarwal SK, Kasula S, Almomani A, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization. Am Heart J. 2017 02; 184:10-16.
    View in: PubMed
    Score: 0.009
  86. Kasula S, Agarwal SK, Hacioglu Y, Pothineni NK, Bhatti S, Ahmed Z, Uretsky B, Hakeem A. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes. Heart. 2016 12 15; 102(24):1988-1994.
    View in: PubMed
    Score: 0.008
  87. Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016 05 23; 9(10):1022-31.
    View in: PubMed
    Score: 0.008
  88. MacGowan GA, Murali S, Loftus S, Uretsky BF. Comparison of metabolic, ventilatory, and neurohumoral responses during light forearm isometric exercise and isotonic exercise in congestive heart failure. Am J Cardiol. 1996 Feb 15; 77(5):391-6.
    View in: PubMed
    Score: 0.008
  89. Lazar JM, Uretsky BF. Coronary artery fistula after heart transplantation: a disappearing entity? Cathet Cardiovasc Diagn. 1996 Jan; 37(1):10-3.
    View in: PubMed
    Score: 0.008
  90. Carlino M, Ruparelia N, Thomas G, Brooks M, Uretsky BF, Brilakis ES, Karmpaliotis D, Hanratty C, Walsh S, Spratt J, Colombo A. Modified contrast microinjection technique to facilitate chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2016 May; 87(6):1036-41.
    View in: PubMed
    Score: 0.008
  91. Carlino M, Figini F, Ruparelia N, Uretsky BF, Godino C, Latib A, Bertoldi L, Brilakis E, Karmpaliotis D, Antoniucci D, Margonato A, Colombo A. Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade. Catheter Cardiovasc Interv. 2016 Apr; 87(5):884-92.
    View in: PubMed
    Score: 0.008
  92. Pothineni NV, Bahia A, Gobal F, Ahmed Z, Uretsky BF, Hakeem A. "DVT" of the Heart: A "Novel" Treatment for an Old Problem. JACC Cardiovasc Interv. 2015 Aug 24; 8(10):e165-e166.
    View in: PubMed
    Score: 0.008
  93. Rosenbaum AM, Murali S, Uretsky BF. Intra-aortic balloon counterpulsation as a 'bridge' to cardiac transplantation. Effects in nonischemic and ischemic cardiomyopathy. Chest. 1994 Dec; 106(6):1683-8.
    View in: PubMed
    Score: 0.008
  94. Carell ES, Murali S, Schulman DS, Estrada-Quintero T, Uretsky BF. Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest. 1994 Dec; 106(6):1746-52.
    View in: PubMed
    Score: 0.008
  95. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct; 22(4):955-62.
    View in: PubMed
    Score: 0.007
  96. Hakeem A, Marmagkiolis K, Hacioglu Y, Uretsky BF, Gundogdu B, Leesar M, Bailey SR, Cilingiroglu M. Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2013 Nov-Dec; 14(6):349-55.
    View in: PubMed
    Score: 0.007
  97. Rifkin RD, Uretsky BF. Screening for latent coronary artery disease by fluoroscopic detection of calcium in the coronary arteries. Am J Cardiol. 1993 Feb 15; 71(5):434-6.
    View in: PubMed
    Score: 0.007
  98. Cook J, Uretsky BF, Sachdeva R. Intervention in the occluded vein graft: with high risk can come great reward: review of techniques with case examples. J Invasive Cardiol. 2012 Nov; 24(11):612-7.
    View in: PubMed
    Score: 0.007
  99. Mhatre A, Uretsky BF, Sachdeva R. Substrate for complications. J Invasive Cardiol. 2012 Jul; 24(7):E153-6.
    View in: PubMed
    Score: 0.006
  100. Singla S, Uretsky BF, Sachdeva R. Retrograde fractional flow reserve and recanalization of a chronic total occlusion of a saphenous venous graft. Catheter Cardiovasc Interv. 2012 Dec 01; 80(7):1210-5.
    View in: PubMed
    Score: 0.006
  101. Aleti S, Uretsky BF, Sachdeva R. Utility of fractional flow reserve to determine treatment after recent large myocardial infarction with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):830-4.
    View in: PubMed
    Score: 0.006
  102. Uretsky BF. Sensory reinnervation of the heart after cardiac transplantation. N Engl J Med. 1992 Jan 02; 326(1):66-7; author reply 67-8.
    View in: PubMed
    Score: 0.006
  103. Prayaga S, Uretsky BF, Sachdeva R. ST-elevation myocardial infarction as a complication of retrograde chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2012 Oct 01; 80(4):611-5.
    View in: PubMed
    Score: 0.006
  104. Kalaga R, Uretsky BF, Sachdeva R. Atresia of the left internal mammary artery graft following percutaneous intervention of the left main. J Invasive Cardiol. 2011 Dec; 23(12):E284-7.
    View in: PubMed
    Score: 0.006
  105. Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic changes in cardiac tamponade. Am J Cardiol. 1990 Dec 15; 66(20):1487-91.
    View in: PubMed
    Score: 0.006
  106. Uretsky BF, Verbalis JG, Murali S, Betschart AR, Kolesar JA, Reddy PS. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J Clin Endocrinol Metab. 1990 Jul; 71(1):146-51.
    View in: PubMed
    Score: 0.006
  107. Agarwal M, Uretsky B, Sachdeva R. ST-segment elevation myocardial infarction in severe coronary artery stenosis: a case series. J Invasive Cardiol. 2010 Mar; 22(3):E34-6.
    View in: PubMed
    Score: 0.005
  108. Denys BG, Reddy PS, Uretsky BF. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency. Am J Cardiol. 1989 Aug 01; 64(5):405-6.
    View in: PubMed
    Score: 0.005
  109. Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemaier T. Lisinopril for severe congestive heart failure. Am J Cardiol. 1989 Feb 21; 63(8):8D-11D.
    View in: PubMed
    Score: 0.005
  110. Ye Y, Lin Y, Perez-Polo JR, Uretsky BF, Ye Z, Tieu BC, Birnbaum Y. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. J Immunol. 2008 Sep 01; 181(5):3515-23.
    View in: PubMed
    Score: 0.005
  111. Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemeier T, Rush JE, et al. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses. Am Heart J. 1988 Aug; 116(2 Pt 1):480-8.
    View in: PubMed
    Score: 0.005
  112. Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. Am J Physiol Heart Circ Physiol. 2008 Jul; 295(1):H343-51.
    View in: PubMed
    Score: 0.005
  113. Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv. 2008 Apr 01; 71(5):636-43.
    View in: PubMed
    Score: 0.005
  114. Uretsky BF, Rifkin RD, Sharma SC, Reddy PS. Value of fluoroscopy in the detection of coronary stenosis: influence of age, sex, and number of vessels calcified on diagnostic efficacy. Am Heart J. 1988 Feb; 115(2):323-33.
    View in: PubMed
    Score: 0.005
  115. Uretsky BF. Diagnostic considerations in the adult patient with cardiomyopathy or congestive heart failure. Cardiovasc Clin. 1988; 19(1):35-56.
    View in: PubMed
    Score: 0.005
  116. Manickavasagam S, Ye Y, Lin Y, Perez-Polo RJ, Huang MH, Lui CY, Hughes MG, McAdoo DJ, Uretsky BF, Birnbaum Y. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther. 2007 Oct; 21(5):321-30.
    View in: PubMed
    Score: 0.005
  117. Uretsky BF, Lawless CE, Verbalis JG, Valdes AM, Kolesar JA, Reddy PS. Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy. Chest. 1987 Oct; 92(4):657-62.
    View in: PubMed
    Score: 0.005
  118. Merla R, Ye Y, Lin Y, Manickavasagam S, Huang MH, Perez-Polo RJ, Uretsky BF, Birnbaum Y. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007 Sep; 293(3):H1918-28.
    View in: PubMed
    Score: 0.005
  119. Ye Y, Lin Y, Perez-Polo R, Huang MH, Hughes MG, McAdoo DJ, Manickavasagam S, Uretsky BF, Birnbaum Y. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. Am J Physiol Heart Circ Physiol. 2007 Jul; 293(1):H813-8.
    View in: PubMed
    Score: 0.004
  120. McGehee JT, Rangasetty UC, Atar S, Barbagelata NN, Uretsky BF, Birnbaum Y. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction. J Electrocardiol. 2007 Jan; 40(1):26-33.
    View in: PubMed
    Score: 0.004
  121. Rahko PS, Salerni R, Uretsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol. 1986 Aug; 8(2):436-40.
    View in: PubMed
    Score: 0.004
  122. Saeed M, Rahman A, Afzal A, Agoston I, Jammula P, Birnbaum Y, Ware DL, Uretsky BF, Schwarz ER, Rosanio S. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol. 2006 Nov 18; 113(3):401-5.
    View in: PubMed
    Score: 0.004
  123. Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure. Am J Cardiol. 1986 Jul 01; 58(1):110-6.
    View in: PubMed
    Score: 0.004
  124. Islam J, Uretsky BF, Sierpina VS. Heart failure improvement with CoQ10, Hawthorn, and magnesium in a patient scheduled for cardiac resynchronization-defibrillator therapy: a case study. Explore (NY). 2006 Jul-Aug; 2(4):339-41.
    View in: PubMed
    Score: 0.004
  125. Rahko PS, Shaver JA, Salerni R, Uretsky BF. Noninvasive evaluation of systolic and diastolic function in severe congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1986 Jun 01; 57(15):1315-22.
    View in: PubMed
    Score: 0.004
  126. Atar S, Cannon CP, Murphy SA, Rosanio S, Uretsky BF, Birnbaum Y. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial. Am Heart J. 2006 May; 151(5):976.e1-6.
    View in: PubMed
    Score: 0.004
  127. Shilling K, Uretsky BF, Hunter GC. Entrapment of a cerebral embolic protection device--a case report. Vasc Endovascular Surg. 2006 May-Jun; 40(3):229-33.
    View in: PubMed
    Score: 0.004
  128. Ye Y, Lin Y, Atar S, Huang MH, Perez-Polo JR, Uretsky BF, Birnbaum Y. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3):H1158-69.
    View in: PubMed
    Score: 0.004
  129. Uretsky BF, Seecof RM, Reddy PS. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response. Can J Cardiol. 1986 Mar-Apr; 2(2):80-5.
    View in: PubMed
    Score: 0.004
  130. Rosanio S, Ye Y, Atar S, Rahman AM, Freeberg SY, Huang MH, Uretsky BF, Birnbaum Y. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther. 2006 Feb; 20(1):27-36.
    View in: PubMed
    Score: 0.004
  131. Gupta R, Atar S, Schwarz ER, Uretsky BF, Birnbaum Y. Vineberg procedure for inadvertent injury to anomalous left anterior descending artery during tetralogy of fallot repair: four decades later. Tex Heart Inst J. 2006; 33(1):98-9.
    View in: PubMed
    Score: 0.004
  132. Atar S, Ye Y, Lin Y, Freeberg SY, Nishi SP, Rosanio S, Huang MH, Uretsky BF, Perez-Polo JR, Birnbaum Y. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol. 2006 May; 290(5):H1960-8.
    View in: PubMed
    Score: 0.004
  133. Schwarz ER, Gupta R, Diep TP, Nowak B, Kostin S, Grohmann B, Uretsky BF, Schaper J. Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization. J Cardiovasc Pharmacol Ther. 2005 Sep; 10(3):181-90.
    View in: PubMed
    Score: 0.004
  134. Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. J Am Coll Cardiol. 1985 Jun; 5(6):1414-21.
    View in: PubMed
    Score: 0.004
  135. Gupta R, Rahman MA, Uretsky BF, Schwarz ER. Left main coronary artery thrombus: a case series with different outcomes. J Thromb Thrombolysis. 2005 Apr; 19(2):125-31.
    View in: PubMed
    Score: 0.004
  136. Schuh A, Breuer S, Al Dashti R, Sulemanjee N, Hanrath P, Weber C, Uretsky BF, Schwarz ER. Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Ther. 2005 Mar; 10(1):55-66.
    View in: PubMed
    Score: 0.004
  137. Uretsky BF, Generalovich T, Reddy PS, Salerni R, Valdes AM, Spangenberg RB, Lang JF, Okerholm RA. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. Am J Cardiol. 1984 Aug 01; 54(3):357-62.
    View in: PubMed
    Score: 0.004
  138. Anzuini A, Chiesa R, Vivekananthan K, Uretsky B, Colombo A, Margonato A, Airoldi F, Rosanio S, Augello G, Birnbaum Y, Magnani G, Esposito G, Melissano G, Moura MR, Briguori C. Endovascular stenting for stenoses in surgically reconstructed brachiocephalic bypass grafts: immediate and midterm outcomes. J Endovasc Ther. 2004 Jun; 11(3):263-8.
    View in: PubMed
    Score: 0.004
  139. Tavackoli S, Ashitkov T, Hu ZY, Motamedi M, Uretsky BF, Birnbaum Y. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels. Coron Artery Dis. 2004 Feb; 15(1):53-8.
    View in: PubMed
    Score: 0.004
  140. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003 Jul 16; 290(3):353-9.
    View in: PubMed
    Score: 0.003
  141. Uretsky BF, Generalovich T, Reddy PS, Spangenberg RB, Follansbee WP. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure. Circulation. 1983 Apr; 67(4):823-8.
    View in: PubMed
    Score: 0.003
  142. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Ryd?n L. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003 Jan; 89(1):42-8.
    View in: PubMed
    Score: 0.003
  143. Birnbaum Y, Ashitkov T, Uretsky BF, Ballinger S, Motamedi M. Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther. 2003 Jan; 17(1):25-30.
    View in: PubMed
    Score: 0.003
  144. Mueller RN, Uretsky BF, Hao L, Walker DH, Panomitros GE, Zornow MH. Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogram. Anesthesiology. 2002 Sep; 97(3):745-9.
    View in: PubMed
    Score: 0.003
  145. Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol. 2002 Mar 20; 39(6):946-53.
    View in: PubMed
    Score: 0.003
  146. Uretsky BF. Does mitral valve prolapse cause nonspecific symptoms? Int J Cardiol. 1982; 1(5-6):435-42.
    View in: PubMed
    Score: 0.003
  147. deFilippi CR, Rosanio S, Tocchi M, Parmar RJ, Potter MA, Uretsky BF, Runge MS. Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. J Am Coll Cardiol. 2001 Jun 15; 37(8):2042-9.
    View in: PubMed
    Score: 0.003
  148. Shah MR, Stinnett SS, McNulty SE, Gheorghiade M, Zannad F, Uretsky B, Adams KF, Califf RM, O'connor CM. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. Am Heart J. 2001 Jun; 141(6):908-14.
    View in: PubMed
    Score: 0.003
  149. Rosanio S, Tocchi M, Cutler D, Uretsky BF, Stouffer GA, deFilippi CR, MacInerney EJ, Runge SR, Aaron J, Otero J, Garg S, Runge MS. Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry. JAMA. 1999 Jul 14; 282(2):145-52.
    View in: PubMed
    Score: 0.003
  150. O'Connor CM, Gattis WA, Uretsky BF, Adams KF, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1999 Jul; 138(1 Pt 1):78-86.
    View in: PubMed
    Score: 0.003
  151. Adams KF, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation. 1999 Apr 13; 99(14):1816-21.
    View in: PubMed
    Score: 0.003
  152. Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol. 1998 Sep; 32(3):686-92.
    View in: PubMed
    Score: 0.002
  153. Lo MW, Toh J, Emmert SE, Ritter MA, Furtek CI, Lu H, Colucci WS, Uretsky BF, Rucinska E. Pharmacokinetics of intravenous and oral losartan in patients with heart failure. J Clin Pharmacol. 1998 Jun; 38(6):525-32.
    View in: PubMed
    Score: 0.002
  154. Adams KF, Gheorghiade M, Uretsky BF, Young JB, Patterson JH, Tomasko L, Packer M. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy. Am Heart J. 1998 Mar; 135(3):389-97.
    View in: PubMed
    Score: 0.002
  155. Uretsky BF, Farquhar DS, Berezin AF, Hood WB. Symptomatic myocardial infarction without chest pain: prevalence and clinical course. Am J Cardiol. 1977 Oct; 40(4):498-503.
    View in: PubMed
    Score: 0.002
  156. Adams KF, Gheorghiade M, Uretsky BF, Young JB, Ahmed S, Tomasko L, Packer M. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997 Jul; 30(1):42-8.
    View in: PubMed
    Score: 0.002
  157. Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Wheeler W, Soler-Soler J, Swedberg K. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997 Jul; 134(1):44-54.
    View in: PubMed
    Score: 0.002
  158. Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, J?bsis MM, Blackburn SD, Crow JW, Long WA. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation. 1997 Mar 18; 95(6):1479-86.
    View in: PubMed
    Score: 0.002
  159. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation. 1996 Dec 01; 94(11):2800-6.
    View in: PubMed
    Score: 0.002
  160. Mateo R, Jethmalani S, Angus DC, Gorcsan J, Uretsky B, Fung J. Interferon-associated left ventricular dysfunction in a liver transplant recipient. Dig Dis Sci. 1996 Jul; 41(7):1500-3.
    View in: PubMed
    Score: 0.002
  161. Lavee J, Kormos RL, Uretsky BF, Murali S, Donato W, Hardesty RL, Griffith BP. Prediction of mortality in patients awaiting cardiac transplantation: increased risk of sudden death in ischemic compared to idiopathic dilated cardiomyopathy. Isr J Med Sci. 1996 May; 32(5):282-7.
    View in: PubMed
    Score: 0.002
  162. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, J?bsis MM, Blackburn SD, Shortino D, Crow JW. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996 Feb 01; 334(5):296-301.
    View in: PubMed
    Score: 0.002
  163. Estrada-Quintero T, Uretsky BF, Murali S, Griffith BP, Kormos RL. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. Chest. 1995 Jun; 107(6):1499-503.
    View in: PubMed
    Score: 0.002
  164. Lazar JM, Uretsky BF, Denys BG, Reddy PS, Counihan PJ, Ragosta M. Predisposing risk factors and natural history of acute neurologic complications of left-sided cardiac catheterization. Am J Cardiol. 1995 May 15; 75(15):1056-60.
    View in: PubMed
    Score: 0.002
  165. Sueta CA, Gheorghiade M, Adams KF, Bourge RC, Murali S, Uretsky BF, Pritzker MR, McGoon MD, Butman SM, Grossman SH, et al. Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group. Am J Cardiol. 1995 Jan 19; 75(3):34A-43A.
    View in: PubMed
    Score: 0.002
  166. Rubin DA, Uretsky BF, Zerbe TR, Estrada-Quintero T, Murali S. Increased plasma atrial natriuretic peptide levels after heart transplant: relation to ventricular expression and severity of rejection. Am Heart J. 1994 Oct; 128(4):769-73.
    View in: PubMed
    Score: 0.002
  167. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Denys BG, Armitage JM, Hardesty RL, Griffith BP. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993 Oct; 126(4):896-904.
    View in: PubMed
    Score: 0.002
  168. Denys BG, Uretsky BF, Reddy PS. Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation. 1993 May; 87(5):1557-62.
    View in: PubMed
    Score: 0.002
  169. Murali S, Uretsky BF, Armitage JM, Tokarczyk TR, Betschart AR, Kormos RL, Stein KL, Reddy PS, Hardesty RL, Griffith BP. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant. 1992 Jul-Aug; 11(4 Pt 1):716-23.
    View in: PubMed
    Score: 0.002
  170. Zerbe T, Uretsky B, Kormos R, Armitage J, Wolyn T, Griffith B, Hardesty R, Duquesnoy R. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S104-10.
    View in: PubMed
    Score: 0.002
  171. Estrada-Quintero T, Uretsky BF, Murali S, Hardesty RL. Prolonged intraaortic balloon support for septal rupture after myocardial infarction. Ann Thorac Surg. 1992 Feb; 53(2):335-7.
    View in: PubMed
    Score: 0.002
  172. Hosenpud JD, DeMarco T, Frazier OH, Griffith BP, Uretsky BF, Menkis AH, O'Connell JB, Olivari MT, Valantine HA. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation. 1991 Nov; 84(5 Suppl):III338-43.
    View in: PubMed
    Score: 0.002
  173. Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS. Same-day angioplasty and diagnostic catheterization: safe and effective but riskier in unstable angina. Angiology. 1991 Aug; 42(8):607-13.
    View in: PubMed
    Score: 0.001
  174. Kormos RL, Armitage JM, Hardesty RL, Hattler BG, del Nido P, Marrone GC, Lee A, Uretsky BF, Murali S, Griffith BP. Cardiac transplantation at the University of Pittsburgh: 1980 to 1991. Clin Transpl. 1991; 87-95.
    View in: PubMed
    Score: 0.001
  175. Hosenpud JD, Uretsky BF, Griffith BP, O'Connell JB, Olivari MT, Valantine HA. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. J Heart Transplant. 1990 Jul-Aug; 9(4):346-50.
    View in: PubMed
    Score: 0.001
  176. Kaufman CL, Zeevi A, Kormos RL, Zerbe TR, Keenan RJ, Uretsky BF, Griffith BP, Hardesty RL, Duquesnoy RJ. Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Hum Immunol. 1990 Jun; 28(2):228-36.
    View in: PubMed
    Score: 0.001
  177. Murali S, Uretsky BF, Betschart AR, Tokarczyk TR, Kolesar JA, Reddy PS. Differential hemodynamic effects of oral enoximone in severe congestive heart failure. Am J Cardiol. 1990 Feb 15; 65(7):515-9.
    View in: PubMed
    Score: 0.001
  178. Pahl E, Fricker FJ, Armitage J, Griffith BP, Taylor S, Uretsky BF, Beerman LB, Zuberbuhler JR. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 1990 Feb; 116(2):177-83.
    View in: PubMed
    Score: 0.001
  179. Murali S, Uretsky BF, Reddy PS, Griffith BP, Hardesty RL, Trento A. Hemodynamic abnormalities following cardiac transplantation: relationship to hypertension and survival. Am Heart J. 1989 Aug; 118(2):334-41.
    View in: PubMed
    Score: 0.001
  180. Dowling RD, Reddy PS, Uretsky BF, Steed DL, Webster MW. Comparison of open versus percutaneous exposure of the femoral artery for balloon aortic valvuloplasty. J Vasc Surg. 1989 May; 9(5):749-50.
    View in: PubMed
    Score: 0.001
  181. Stone CK, Uretsky BF, Linnemeier TJ, Shah PK, Amin DK, Snapinn SM, Rush JE, Langend?rfer A, Liang CS. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure. Am J Cardiol. 1989 Mar 01; 63(9):567-70.
    View in: PubMed
    Score: 0.001
  182. Ladowski JS, Kormos RL, Uretsky BF, Lee A, Curran M, Clark R, Armitage JM, Griffith BP, Hardesty RL. Posttransplantation diabetes mellitus in heart transplant recipients. J Heart Transplant. 1989 Mar-Apr; 8(2):181-3.
    View in: PubMed
    Score: 0.001
  183. Sandhu JS, Uretsky BF, Zerbe TR, Goldsmith AS, Reddy PS, Kormos RL, Griffith BP, Hardesty RL. Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsy. Circulation. 1989 Feb; 79(2):350-6.
    View in: PubMed
    Score: 0.001
  184. Murali S, Uretsky BF, Kolesar JA, Valdes AM, Reddy PS. The acute effect of an oral "inotropic" placebo on the exercise capacity of patients with chronic cardiac failure. Chest. 1988 Aug; 94(2):262-6.
    View in: PubMed
    Score: 0.001
  185. Curtiss EI, Reddy PS, Uretsky BF, Cecchetti AA. Pulsus paradoxus: definition and relation to the severity of cardiac tamponade. Am Heart J. 1988 Feb; 115(2):391-8.
    View in: PubMed
    Score: 0.001
  186. Murali S, Uretsky BF, Valdes AM, Kolesar JA, Reddy PS. Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure. Am J Cardiol. 1987 Jun 01; 59(15):1356-60.
    View in: PubMed
    Score: 0.001
  187. Curtiss EI, Fogoros RN, Uretsky BF, Follansbee WP, Salerni R. Electrocardiographically discrete right and left ventricular QRS complexes: a case report. J Electrocardiol. 1987 Apr; 20(2):162-8.
    View in: PubMed
    Score: 0.001
  188. Unverferth DV, O'Dorisio TM, Miller MM, Uretsky BF, Magorien RD, Leier CV, Thompson ME, Hamlin RL. Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. J Lab Clin Med. 1986 Jul; 108(1):11-6.
    View in: PubMed
    Score: 0.001
  189. Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BF, Thompson ME, Leier CV. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986 Apr 01; 57(10):816-20.
    View in: PubMed
    Score: 0.001
  190. Greenberg ML, Uretsky BF, Reddy PS, Bernstein RL, Griffith BP, Hardesty RL, Thompson ME, Bahnson HT. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation. 1985 Mar; 71(3):487-94.
    View in: PubMed
    Score: 0.001
  191. Reddy PS, Uretsky BF, Steinfeld M. The hemodynamic effects of intravenous verapamil in patients on chronic propranolol therapy. Am Heart J. 1984 Jan; 107(1):97-101.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.